B-Organ	0	4	Skin	Skin	NN	B-NP
O	5	9	deep	deep	JJ	B-ADJP
O	10	13	and	and	CC	I-ADJP
O	14	20	deeper	deep	JJR	I-ADJP
O	20	21	:	:	:	O
O	22	30	multiple	multiple	JJ	B-NP
O	31	39	pathways	pathway	NNS	I-NP
O	40	42	in	in	IN	B-PP
B-Cell	43	48	basal	basal	JJ	B-NP
I-Cell	49	53	cell	cell	NN	I-NP
O	54	68	carcinogenesis	carcinogenesis	NN	I-NP
O	68	69	.	.	.	O

O	71	75	This	This	DT	B-NP
O	76	87	perspective	perspective	NN	I-NP
O	88	94	places	place	VBZ	B-VP
O	95	98	the	the	DT	B-NP
O	99	105	report	report	NN	I-NP
O	106	108	by	by	IN	B-PP
O	109	116	Villani	Villani	NNP	B-NP
O	117	119	et	et	FW	I-NP
O	120	122	al	al	FW	I-NP
O	122	123	.	.	.	O
O	124	128	that	that	WDT	B-NP
O	129	136	appears	appear	VBZ	B-VP
O	137	139	in	in	IN	B-PP
O	140	144	this	this	DT	B-NP
O	145	150	issue	issue	NN	I-NP
O	151	153	of	of	IN	B-PP
O	154	157	the	the	DT	B-NP
O	158	165	journal	journal	NN	I-NP
O	166	167	(	(	(	O
O	167	176	beginning	begin	VBG	B-VP
O	177	179	on	on	IN	B-PP
O	180	184	page	page	NN	B-NP
O	185	189	1222	1222	CD	I-NP
O	189	190	)	)	)	O
O	191	193	in	in	IN	B-PP
O	194	197	the	the	DT	B-NP
O	198	205	context	context	NN	I-NP
O	206	208	of	of	IN	B-PP
O	209	215	recent	recent	JJ	B-NP
O	216	220	work	work	NN	I-NP
O	221	228	showing	show	VBG	B-VP
O	229	231	an	an	DT	B-NP
O	232	244	intersection	intersection	NN	I-NP
O	245	252	between	between	IN	B-PP
O	253	256	two	two	CD	B-NP
O	257	266	important	important	JJ	I-NP
O	267	280	developmental	developmental	JJ	I-NP
O	281	289	pathways	pathway	NNS	I-NP
O	290	300	implicated	implicate	VBN	B-VP
O	301	303	in	in	IN	B-PP
O	304	315	oncogenesis	oncogenesis	NN	B-NP
O	315	316	:	:	:	O
O	317	320	the	the	DT	B-NP
O	321	329	hedgehog	hedgehog	NN	I-NP
O	330	333	and	and	CC	I-NP
O	334	341	insulin	insulin	NN	I-NP
O	341	342	-	-	HYPH	B-NP
O	342	346	like	like	JJ	I-NP
O	347	353	growth	growth	NN	I-NP
O	354	360	factor	factor	NN	I-NP
O	361	362	(	(	(	O
O	362	365	IGF	IGF	NN	B-NP
O	365	366	)	)	)	O
O	367	375	pathways	pathway	NNS	B-NP
O	375	376	.	.	.	O

O	377	384	Villani	Villani	NNP	B-NP
O	385	387	et	et	FW	I-NP
O	388	390	al	al	FW	I-NP
O	390	391	.	.	.	O
O	392	398	define	define	VB	B-VP
O	399	400	a	a	DT	B-NP
O	401	404	key	key	JJ	I-NP
O	405	409	role	role	NN	I-NP
O	410	413	for	for	IN	B-PP
O	414	417	the	the	DT	B-NP
O	418	421	IGF	IGF	NN	I-NP
O	422	432	regulatory	regulatory	JJ	I-NP
O	433	440	protein	protein	NN	I-NP
O	441	447	Igfbp2	Igfbp2	NN	I-NP
O	448	450	in	in	IN	B-PP
O	451	452	a	a	DT	B-NP
O	453	460	genetic	genetic	JJ	I-NP
O	461	466	model	model	NN	I-NP
O	467	469	of	of	IN	B-PP
B-Cell	470	475	basal	basal	JJ	B-NP
I-Cell	476	480	cell	cell	NN	I-NP
O	481	495	carcinogenesis	carcinogenesis	NN	I-NP
O	496	502	driven	drive	VBN	B-VP
O	503	505	by	by	IN	B-PP
O	506	514	targeted	target	VBN	B-NP
O	515	527	constitutive	constitutive	JJ	I-NP
O	528	538	activation	activation	NN	I-NP
O	539	541	of	of	IN	B-PP
O	542	550	hedgehog	hedgehog	NN	B-NP
O	551	560	signaling	signaling	NN	I-NP
O	560	561	.	.	.	O

O	562	568	Placed	Place	VBN	B-VP
O	569	571	in	in	IN	B-PP
O	572	575	the	the	DT	B-NP
O	576	585	framework	framework	NN	I-NP
O	586	588	of	of	IN	B-PP
O	589	594	other	other	JJ	B-NP
O	595	603	recently	recently	RB	I-NP
O	604	613	published	publish	VBN	I-NP
O	614	618	work	work	NN	I-NP
O	618	619	,	,	,	O
O	620	623	the	the	DT	B-NP
O	624	636	observations	observation	NNS	I-NP
O	637	639	of	of	IN	B-PP
O	640	647	Villani	Villani	NNP	B-NP
O	648	650	et	et	FW	I-NP
O	651	653	al	al	FW	I-NP
O	653	654	.	.	.	O
O	655	659	both	both	CC	O
O	660	665	raise	raise	VBP	B-VP
O	666	675	questions	question	NNS	B-NP
O	676	681	about	about	IN	B-PP
O	682	685	the	the	DT	B-NP
B-Cell	686	690	cell	cell	NN	I-NP
O	691	693	of	of	IN	B-PP
O	694	700	origin	origin	NN	B-NP
O	701	704	for	for	IN	B-PP
B-Cancer	705	710	basal	basal	JJ	B-NP
I-Cancer	711	715	cell	cell	NN	I-NP
I-Cancer	716	723	cancers	cancer	NNS	I-NP
O	724	727	and	and	CC	O
O	728	734	define	define	VB	B-VP
O	735	745	additional	additional	JJ	B-NP
O	746	754	putative	putative	JJ	I-NP
O	755	766	therapeutic	therapeutic	JJ	I-NP
O	767	770	and	and	CC	I-NP
O	771	781	preventive	preventive	JJ	I-NP
O	782	789	targets	target	NNS	I-NP
O	790	793	for	for	IN	B-PP
O	794	798	this	this	DT	B-NP
O	799	806	disease	disease	NN	I-NP
O	806	807	.	.	.	O

